Women get less information on post-cancer fertility: study

Key points
- Cancer treatment can sometimes lead to infertility, but young women are far less likely than young men to be informed of this, according to a Swedish study.
- Findings published in the Journal of Clinical Oncology found that of nearly 500 cancer survivors aged 18 to 45, 80 percent of men surveyed said their doctor had told them their chemotherapy could affect their future fertility.
- In addition, only 14 percent of women said they received information on options to preserve their fertility, versus 68 percent of men.
- The gap is likely related to the fact that preserving fertility is more complicated in women than men and techniques for doing so are not as widely available, said the researchers.
Cancer treatment can sometimes lead to infertility, but young women are far less likely than young men to be informed of this, according to a Swedish study.
Findings published in the Journal of Clinical Oncology found that of nearly 500 cancer survivors aged 18 to 45, 80 percent of men surveyed said their doctor had told them their chemotherapy could affect their future fertility.
But only 48 percent of women said the same. In addition, only 14 percent of women said they received information on options to preserve their fertility, versus 68 percent of men.
The gap is likely related to the fact that preserving fertility is more complicated in women than men and techniques for doing so are not as widely available, said the researchers.
"Even in cases when fertility preservation could not be performed, patients - and in particular, women - should be informed about their risk of decreased fertility and their risk of entering menopause prematurely," senior researcher Claudia Lampic, of the Karolinska Institute in Stockholm, told Reuters Health in an email.
Some chemotherapy drugs can damage a woman's eggs or a man's ability to produce normal sperm. Radiation therapy near the reproductive organs, or to the brain, can harm fertility, as can hormonal therapies for breast, prostate and other cancers.
Many women of childbearing age who have been diagnosed with cancer think that preserving their fertility is important and want information about their options. However,
- Patients may not feel comfortable bringing up fertility issues.
- Patients may not be aware of their options for preserving fertility.
- Patients may be focused on their cancer diagnosis and unable to think about fertility or the possibility of having a future family.
- Women may later regret not considering fertility issues prior to starting cancer treatment.
Understanding that there are fertility preservation options available and referring at-risk patients to specialists can improve patients’ emotional outlook and future quality of life.
Even women with a poor prognosis may want to consider fertility preservation.
A recent U.S. survey of women diagnosed with cancer when they were 40 or younger found that more than half said they still wanted to have children at the time of their diagnosis.
"The options are out there, but the utility is still patchwork right now," Oktay said.
Men can have their sperm frozen and banked before cancer treatment, a relatively quick and simple process that is also comparatively inexpensive.
Starting the Conversation You may not be comfortable speaking with your patients about the risk of infertility related to their cancer or planned cancer treatment. These key points can help start the conversation:
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsStudy may help reassure women taking tamoxifen for breast cancer
A study led by Loyola Medicine researchers may help reassure patients who worry the breast cancer drug tamoxifen could increase their risk of uterine cancer. The multi-center study was presented during the 2016 annual…
7 June 2016
NewsCancer survivors less likely to receive callbacks from potential employers
Job applicants who are cancer survivors are less likely to receive callbacks from potential retail employers than those who did not disclose their health history, according to a recent study by Rice University and Penn…
7 November 2015
NewsMore men at risk for prostate cancer as a result of less regular screening
The U.S. Preventive Services Task Force (USPSTF) recommendation against regular prostate specific antigen (PSA) screening for prostate cancer is controversial. While it may reduce the risk of over diagnosis and…






